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Abstract
Background: Neurons in superficial (SDH) and deep (DDH) laminae of the spinal cord dorsal
horn receive sensory information from skin, muscle, joints and viscera. In both regions, glycine-
(GlyR) and GABAA-receptors (GABAARs) contribute to fast synaptic inhibition. For rat, several
types of GABAAR coexist in the two regions and each receptor type provides different
contributions to inhibitory tone. Recent work in mouse has discovered an additional type of GlyR,
(containing alpha 3 subunits) in the SDH. The contribution of differing forms of the GlyR to sensory
processing in SDH and DDH is not understood.
Methods and Results: Here we compare fast inhibitory synaptic transmission in mouse (P17-37)
SDH and DDH using patch-clamp electrophysiology in transverse spinal cord slices (L3-L5
segments, 23°C). GlyR-mediated mIPSCs were detected in 74% (25/34) and 94% (25/27) of SDH
and DDH neurons, respectively. In contrast, GABAAR-mediated mIPSCs were detected in virtually
all neurons in both regions (93%, 14/15 and 100%, 18/18). Several Gly- and GABAAR properties
also differed in SDH vs. DDH. GlyR-mediated mIPSC amplitude was smaller (37.1 ± 3.9 vs. 64.7 ±
5.0 pA; n = 25 each), decay time was slower (8.5 ± 0.8 vs. 5.5 ± 0.3 ms), and frequency was lower
(0.15 ± 0.03 vs. 0.72 ± 0.13 Hz) in SDH vs. DDH neurons. In contrast, GABAAR-mediated mIPSCs
had similar amplitudes (25.6 ± 2.4, n = 14 vs. 25. ± 2.0 pA, n = 18) and frequencies (0.21 ± 0.08 vs.
0.18 ± 0.04 Hz) in both regions; however, decay times were slower (23.0 ± 3.2 vs. 18.9 ± 1.8 ms)
in SDH neurons. Mean single channel conductance underlying mIPSCs was identical for GlyRs (54.3
± 1.6 pS, n = 11 vs. 55.7 ± 1.8, n = 8) and GABAARs (22.7 ± 1.7 pS, n = 10 vs. 22.4 ± 2.0 pS, n =
1 1 )  i n  b o t h  r e g i o n s .  W e  a l s o  t e s t e d  w h e t her the synthetic endocanabinoid, methandamide
(methAEA), had direct effects on Gly- and GABAARs in each spinal cord region. MethAEA (5 μM)
reduced GlyR-mediated mIPSC frequency in SDH and DDH, but did not affect other properties.
Similar results were observed for GABAAR mediated mIPSCs, however, rise time was slowed by
methAEA in SDH neurons.
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Conclusion: Together these data show that Gly- and GABAARs with clearly differing physiological
properties and cannabinoid-sensitivity contribute to fast synaptic inhibition in mouse SDH and
DDH.
Background
The superficial and deep laminae of the spinal cord dorsal
horn, termed SDH and DDH respectively, are important
sites for processing sensory information arising in skin,
muscle, joints and viscera [1,2]. This information arrives
in the dorsal horn via primary afferents, which have spe-
cific termination patterns in SDH (laminae I-II) and DDH
(laminae IV-VI) depending on their axon diameter, sen-
sory modality and peripheral origin [3-5]. The SDH
receives inputs predominately from small diameter Aδ
and C-fibres carrying nociceptive, thermal, itch, and
innocuous tactile information [6-11]. In contrast, the
DDH receives inputs predominately from larger Aβ mye-
linated fibres carrying tactile information [3,12,13].
As with primary afferent inputs, the outputs of the SDH
and DDH, which are conveyed by projection neurons,
also differ. Projections from the SDH terminate mostly in
brainstem and midbrain centres such as the parabrachial
nuclei and periaqueductal grey [14,15]. In contrast, pro-
jections from the DDH terminate mainly in the thalamus
[16,17]. Recent evidence also suggests intrinsic synaptic
connectivity differs in the two regions. For example,
paired recordings in SDH neurons show a modular pat-
tern of synaptic linkages connecting a restricted number
of neuron types [18,19]. Similar recordings in the DDH
suggest a more extensive synaptic connectivity among
neuron classes [20].
These recent data suggest synaptic processing mechanisms
differ in the SDH and DDH. Indeed, some aspects of fast
inhibitory synaptic transmission, mediated by GABAA and
glycine receptors (GlyRs) differ in the SDH and DDH. For
example, c-Fos expression differs in the SDH and DDH
after blockade of tonic inhibition with specific GABAA and
GlyR antagonists [21] and an unusual form of the GlyR,
containing alpha 3-subunits, is confined to the SDH of
the mouse spinal cord [22]. These data suggest the two
receptors play differing roles in setting inhibitory tone
and subsequent processing of sensory information in the
two regions.
The type-one cannabinoid receptor (CB1R), which has
long been known to be involved in analgesia [23,24], is
also expressed at different levels in the SDH versus DDH
[25]. The CB1R appears to be more highly expressed in the
SDH, consistent with the analgesic action of cannabi-
noids. Several mechanisms have been proposed for the
analgesic action of cannabinoids including modulation of
glutamatergic [26,27], noradrenergic [28] and opioidergic
systems [29,30]. In addition to these CB1R mediated
effects, several reports have suggested cannabinoids also
act directly on GlyRs [31,32]. One study reported attenu-
ation of glycinergic currents by cannabinoids in isolated
hippocampal and Purkinje neurons [32], whereas another
has reported cannabinoids potentiate glycine-activated
currents in isolated ventral tegmental area neurons and in
recombinant GyRs [31]. No studies have investigated the
effects of cannabinoids on "native", synaptically located
GlyRs on SDH or DDH neurons.
In this paper, we first characterize synaptically-mediated
miniature inhibitory postsynaptic currents (mIPSCs) in
both the SDH and DDH of the mouse spinal cord using
patch clamp techniques. We then test whether the syn-
thetic endocannabinoid, methanadamide (methAEA),
has direct effects on synaptically located Gly- and
GABAARs in the SDH and DDH. Finally, we use real-time
PCR (qPCR) to quantify and compare subunit expression
of Gly- and GABAARs, and the CB1R in the SDH and DDH.
Methods
Tissue preparation
All experimental procedures were approved by the Univer-
sity of Newcastle Animal Care and Ethics Committee.
Mice (C57/Bl6; both sexes, aged 17-37 days) were anaes-
thetized with Ketamine (100 mg kg-1 i.p.) and decapi-
tated. The vertebral column (~T5 - S1) was isolated and
immersed in ice-cold oxygenated sucrose substituted arti-
ficial cerebro-spinal fluid (S-ACSF). This solution con-
tained (in mM): 250 sucrose, 25 NaHCO3, 10 glucose, 2.5
KCl, 1 NaH2PO4, 1 MgCl2 and 2.5 CaCl2 and was bubbled
with Carbogen (95% O2 and 5% CO2). The lumbar spinal
cord (L1 - L6) was removed, placed against a Styrofoam
support block, and glued (rostral side down) to a cutting
platform with cyanoacrylate glue (Loctite 454, Loctite,
Caringbah, Australia). The cutting platform was then
transferred to a cutting chamber, filled with ice-cold S-
ACSF, and transverse slices (300 μm-thick) were obtained
from the L3-L5 segments using a vibratome (Leica
Microsystems, Wetzlar, Germany). Slices were transferred
to a storage chamber containing Carbogen-bubbled artifi-
cial cerebro-spinal fluid (ACSF; 118 mM NaCl substituted
for sucrose in S-ACSF) and allowed to equilibrate for 1 h
before electrophysiological recording.
Electrophysiology
Individual slices were transferred to a recording chamber
(bath volume 0.4 ml) and continually perfused (exchange
rate 4-6 bath volumes/min) with bubbled ACSF. NeuronsMolecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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were visualized in spinal cord slices using infrared differ-
ential interference contrast optics (IR-DIC) and a Hama-
matsu charge coupled device camera (Model C-2400-
79H, Hamamatsu City, Japan) linked to a video monitor.
Under IR-DIC lamina II appears as a translucent band that
clearly delineates the lamina II-III border in mice older
than six days (P6) [33]. All SDH recordings were made
between this border and the dorsal white matter. We
defined the DDH as the grey matter dorsal to the central
canal, and more than 100 μm ventral to lamina II. All our
DDH recordings were made within these boundaries.
Patch pipettes (3-4 MΩ resistance), made from borosili-
cate glass (1.5 mm O.D; PG150T-15; Harvard Apparatus,
UK) were filled with an internal solution containing (in
mM): 130 CsCl, 10 HEPES, 10 EGTA, 1 MgCl2, 2 ATP and
0.3 GTP (pH adjusted to 7.35 with 1 M CsOH). Under
these recording conditions the reversal potential for chlo-
ride ions is 0 mV: thus, at a holding potential of -70 mV
all chloride-mediated inhibitory currents are inward.
Whole-cell voltage-clamp recordings were made at room
temperature (22 - 24°C) from SDH and DDH neurons.
After obtaining the whole-cell recording configuration,
series resistance and neuronal input resistance were
assessed according to the response to a 5 mV hyperpolar-
izing step (average of 20 repetitions, holding potential -70
mV). These values were monitored at the beginning and
end of each recording session, and data were rejected if
values changed by > 20%. Series resistance (< 20 MΩ) was
uncompensated in all experiments. All synaptic currents
were recorded at a holding potential of -70 mV using an
Axopatch 200B amplifier (Molecular Devices, Sunnyvale,
CA, USA). Signals were filtered at 2 kHz and digitized on-
line at 10 kHz via an Instrutech ITC-16i A/D board
(Instrutech, Long Island, NY, USA). Data were stored on a
Macintosh G4 computer and analysed offline using Axo-
graph v4.6 software (Molecular Devices, Sunnyvale, CA,
USA).
Experimental protocols
mIPSCs, which are considered to be the postsynaptic
response to the spontaneous release of single vesicles of
neurotransmitter [34], were recorded as follows. GlyR-
mediated mIPSCs were pharmacologically isolated by
bath application of the AMPA-kainate receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 μM),
the GABAA receptor antagonist bicuculline (10 μM), and
the sodium channel blocker tetrodotoxin (TTX; 1 μM).
Data collection commenced 3 minutes after drugs were
washed into the recording bath (wash-on) and continued
for at least another 3 minutes. These mIPSCs were com-
pletely abolished by subsequent bath application of the
GlyR antagonist strychnine (1 μM; n = 10). GABAAR-
mediated mIPSCs were pharmacologically isolated in
CNQX (10 μM), strychnine (1 μM), and TTX (1 μM), and
were abolished by bath application of bicuculline (10 μM;
n = 10). The effect of the synthetic endocannabinoid,
methAEA (5 μM), on GlyR- and GABAAR -mediated mIP-
SCs was tested in a subset of neurons where mIPSC fre-
quency was relatively high (> 1 Hz). MethAEA was
allowed to wash-on for at least 10 minutes before mIPSCs
were recorded for analysis. Each recorded neuron's loca-
tion was carefully noted and mapped as described previ-
ously at the completion of each recording session [35].
The templates for L3, L4, and L5 spinal cord segments
(Figure 1) were adapted from Franklin and Paxinos'
Mouse Brain Atlas [36].
Analysis of mIPSC properties
Pharmacologically isolated GlyR- and GABAAR -mediated
mIPSCs were detected and captured using a sliding tem-
plate method (semi-automated procedure within Axo-
graph software package [37]). Captured mIPSCs were
inspected individually and accepted for analysis when: (1)
the captured trace did not contain overlapping mIPSCs;
(2) the baseline before the rise, or after the decay phase of
the mIPSC trace was stable for > 5 ms; and (3) no time-
dependent trend was evident in either mIPSC amplitude
or instantaneous frequency over the recording period
[38]. Analyses were performed on averaged mIPSCs,
obtained by aligning the rising phase of all accepted mIP-
SCs for a given neuron. Peak amplitude, rise time (calcu-
lated over 10-90% of peak amplitude), and decay time
constant (calculated over 20-80% of the decay phase)
were calculated using semi-automated procedures within
Axograph software. In both SDH and DDH neurons,
GlyR- and GABAAR-mediated mIPSCs were best fit by a
single decay time constant [39].
Analysis of single channel conductance
The single-channel conductance underlying mIPSCs was
determined by peak scaled nonstationary noise analysis
[40] using the Mini Analysis Program (v6; Synaptosoft,
Fort Lee, NJ, USA). This procedure calculates a weighted
mean of the underlying multiple conductance states for
synaptically located receptors, that is, those generating the
recorded mIPSCs versus receptors located outside the syn-
aptic cleft. Briefly, for each neuron, mIPSCs were aligned
at the midpoint of their rising phase and averaged. This
averaged mIPSC was then scaled to the peak amplitude of
all captured mIPSCs that contributed to the averaged
mIPSC. The peak scaled average current was then sub-
tracted from individual (scaled) mIPSCs to obtain a differ-
ence current, which represents random receptor
fluctuations around the mean. Difference currents were
binned over the decay phase of the mIPSC. The variance
was then plotted against the mean current. A parabolic
function (variance = I [current] - [current2]/NP + baseline
noise) was then fit to the variance/mean plot, where I is
single-channel current, N is the average number of chan-
nels open at mIPSC peak, and P is open probability [40].Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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RNA extraction and relative real-time PCR
A separate set of experiments were undertaken to quantify
Gly-, GABAAR and CB1R subunit mRNA. Spinal cord slices
were prepared as described above and each slice was
microdissected into 2 regions containing the SDH and
DDH. This procedure yielded two pieces of tissue per slice.
The SDH and DDH regions for all slices (six slices, L3 - L5)
were pooled by region, and prepared for relative real-time
PCR (qPCR). Total RNA was extracted from the tissue
using TRIzol reagent (Invitrogen, USA) [41]. Tissue was
added to TRIzol reagent and total RNA was prepared
according to the manufacturer's instructions. RNA integ-
rity was assessed by A260/A280 ratios (> 1.8), or visuali-
sation of 18s and 28s ribosomal bands by electrophoresis
with formaldehyde denaturing 1% agarose gel. Total RNA
was treated with DNAse1 (Invitrogen, USA) and reverse
transcribed with SuperscriptII reverse transcriptase (Invit-
rogen, USA) as per manufacturer's instructions. Real-time
PCR using SYBR Green PCR Mastermix (PE Applied Bio-
systems, UK) and an ABI prism 7500 sequence detection
system (PE Applied Biosystems, UK) was performed to
assess the expression of the GlyR subunit genes (α1-4 and
β), GABAAR subunit genes (α1-α3,α5, β2-3,γ2) and CB1R
levels. Primers (Additional File 1) were designed for each
gene using Primer Premier 5.0 (Premier Biosoft Interna-
tional, USA). Reactions consisting of 2 × SYBR Green PCR
Mastermix, 40 nM of each primer, cDNA template, and
nuclease-free water were run in triplicate for each gene on
the ABI 7500 sequence detection system under the follow-
ing conditions: 50°C for 2 min, 95°C for 10 min, 45
cycles of 95°C for 15 s and 60°C for 90 s. Dissociation
curves consisting of 95°C for 15 s and 60°C for 15 s, fol-
lowed by a 2% ramp to 95°C were used to ensure a single
product of the correct molecular size was present in each
reaction. An average cycle threshold value (Ct) was calcu-
lated from triplicate results for each gene. Threshold val-
ues were normalized to the housekeeping gene β-actin to
provide  ΔCt values. Relative expression levels for each
gene were then calculated using the formula 2-ΔCt. Finally,
we calculated a ratio for all GlyR- and GABAAR- subunits
in a given sample (eg, GlyR α1:α2) and then compared
the average ratios between the SDH and DDH.
Statistical analysis
SPSS v13 software package (SPSS Inc. IL, USA) was used
for all statistical analyses. Student's unpaired t-tests were
used to compare mIPSC properties recorded in the SDH
and DDH, and to compare mIPSC properties before and
after exposure to methAEA. One-way ANOVA's compared
gene expression data for all GlyR- and GABAAR subunits
in the SDH and DDH. Student's unpaired t-tests com-
pared gene expression for each subunit (GlyR, GABAAR
and CB1) in the SDH versus DDH. When data were not
normally distributed non-parametric statistics (Mann-
Whitney two sample tests) were applied. All values are
presented as means ± SEM. Statistical significance was set
at p < 0.05.
Drugs
TTX was obtained from Alomone Laboratories (Jerusalem,
Israel), and methAEA from Tocris Bioscience (Bristol,
UK). All other drugs were purchased from Sigma Chemi-
cals (St Louis, MO, USA).
Results
Whole-cell patch clamp recordings were obtained from 92
neurons in 18 animals in either the SDH (n = 45) or the
DDH (n = 47) as illustrated in Figure 1. Mean animal age
(21.4 ± 0.3 vs. 21.9 ± 0.3 days) and series resistance (11.6
± 0.7 vs. 11.6 ± 0.6 MΩ) were similar for SDH and DDH
recordings, suggesting neither age nor recording condi-
tions influenced our results. In contrast, input resistance
was higher in SDH neurons (640 ± 65 vs. 260 ± 30 MΩ).
This is consistent with morphology data, which shows
SDH neurons are smaller than those in the DDH [42,43].
GlyR-mediated mIPSCs were detected in 74% (25/34) of
SDH neurons and in almost all DDH neurons (93%; 25/
Location of recorded SDH and DDH neurons in lumbosacral  spinal cord Figure 1
Location of recorded SDH and DDH neurons in lum-
bosacral spinal cord. The location of each recorded neu-
ron was plotted on templates of the L3, L4, and L5 spinal 
cord segments. Approximately 30 neurons were recorded in 
each segment. For SDH neurons, recordings were obtained 
across the entire medio-lateral extent of the dorsal horn. For 
DDH neurons, recordings were concentrated in the medial 
two thirds of the dorsal horn because dense myelination 
impedes visualizing neurons in lateral DDH.Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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27). In contrast, GABAAR-mediated mIPSCs were detected
in virtually all neurons in our dorsal horn recordings: 93%
(14/15) and 100% (18/18) for SDH and DDH neurons,
respectively. Thus, inhibitory synaptic transmission at
GlyR-containing synapses is more prominent in the DDH,
whereas GABAAR containing synapses are distributed sim-
ilarly in both regions of the mouse spinal cord dorsal
horn.
Glycine receptor-mediated synaptic transmission
Figure 2 and Table 1 compare the properties of GlyR-
mediated mIPSCs recorded in SDH and DDH neurons.
Mean mIPSC amplitude in SDH neurons was approxi-
mately half that observed in DDH neurons (37.1 ± 3.9 vs.
64.7 ± 5.0 pA, n = 25 and n = 25 respectively; Figure 2A
&2C). mIPSC kinetics also differed between the two
regions. The decay time constant for mIPSCs was slower in
SDH versus DDH neurons (8.5 ± 0.8 vs. 5.5 ± 0.3 ms),
however, mIPSC rise times were identical in the two
regions (0.85 ± 0.07 vs. 0.85 ± 0.04 ms). mIPSC frequency
was lower in the SDH compared to the DDH (0.15 ± 0.03
vs. 0.72 ± 0.13 Hz). Interestingly, the combined effect of
smaller slow decaying mIPSCs in the SDH and larger fast
decaying mIPSCs in the DDH resulted in a similar charge
transfer per mIPSC in the two regions (364.5 ± 57.7 vs.
456.6 ± 39.9 pA.ms). However, when glycinergic charge is
multiplied by mIPSC frequency, to provide an overall
measure of glycinergic drive, the result is a more than
seven fold greater drive in DDH versus SDH (68.0 ± 26.8
vs. 400.0 ± 107.9 pA.ms.Hz). Of course under in vivo con-
ditions neurotransmitter release is driven largely by action
potential invasion of presynaptic terminals. Thus, in vivo
differences in background discharge (not assessed in this
study) will contribute to overall levels of glycinergic drive
in the two regions.
The marked differences in GlyR-mediated mIPSC ampli-
tude in SDH and DDH neurons could be attributable to
specific properties of the GlyR, such as differences in sin-
gle-channel conductance, number of receptors open dur-
ing quantal release (No), or channel open probability
(Po). To distinguish between these possibilities, peak-
scaled nonstationary noise analysis was undertaken on a
subset of mIPSC recordings from SDH and DDH neurons
(Table 1). This analysis showed both unitary conductance
(54.3 ± 1.6 vs. 55.7 ± 1.8 pS, n = 8 and n = 11, respec-
tively) and Po (0.97 ± 0.01 vs. 0.99 ± 0.01), were identical
for GlyRs in the SDH and DDH, however, only half the
number of channels (10.3 ± 0.5 vs. 19.0 ± 5.3) contrib-
uted to mean quantal current in the SDH versus DDH.
GABAA receptor-mediated synaptic transmission
Many of the properties of GABAAR-mediated mIPSCs were
similar in SDH and DDH neurons (Table 1, Figure 3).
Specifically, mIPSC amplitude (25.6 ± 2.4 vs. 25.3 ± 2.0
pA, n = 14 and n = 18, respectively) and frequency (0.21
± 0.08 vs 0.18 ± 0.04 Hz) were similar in both regions
(Figure 3A &3C). The rise time and decay time constant of
GABAAR-mediated mIPSCs, however, was significantly
slower in the SDH (1.97 ± 0.18 vs. 1.49 ± 0.10 ms, and
23.0 ± 3.2 vs. 18.9 ± 1.6 ms). Interestingly, the slower
decay times of GABAA-mediated mIPSCs in the SDH
resulted in a significantly greater charge transfer per
mIPSC in SDH versus DDH neurons (717.3 ± 75.5 vs.
486.3 ± 52.4 pA.ms). GABAAR-mediated drive, as esti-
mated by measuring mIPSC charge transfer by event fre-
quency, however, was similar in both regions (152.4 ±
61.9 vs. 92.8 ± 21.1 pA.ms.Hz).
Peak-scaled nonstationary noise analysis was also applied
to GABAAR-mediated mIPSCs to examine the properties
of synaptically located receptors. This analysis showed
that GABAARs underlying the mIPSCs had an identical
unitary conductance in the SDH and DDH (22.7 ± 1.7 vs.
22.4 ± 2.0 pS, n = 8 and n = 11, respectively). Po was lower
in SDH neurons (0.76 ± 0.04 vs. 0.94 ± 0.02) and No was
greater in SDH neurons (18.5 ± 1.6 vs. 12.9 ± 1.0). These
data suggest more GABAA  channels underlie quantal
transmission in the SDH but open probability is lower.
Cannabinoid effects on GlyR-mediated synaptic 
transmission
Two studies have suggested that cannabinoids have direct
(allosteric) effects on recombinant or cultured GlyRs
[31,44]. To test for direct cannabinoid effects on native
GlyRs in the SDH or DDH we compared the properties of
GlyR-mediated mIPSCs, recorded in both regions, before
and after bath application of the synthetic endocannabi-
noid, methAEA (5 μM). Figure 4A shows the effect of
methAEA on glycinergic mIPSCs in the SDH. MethAEA
significantly reduced mIPSC frequency (0.18 ± 0.03 vs.
0.08 ± 0.02 Hz, n = 7). In contrast, methAEA had no effect
on mIPSC amplitude (35.9 ± 5.7 vs. 31.7 ± 3.4 pA), rise
time (0.81 ± 0.16 vs. 0.96 ± 0.08 ms), or decay time con-
stant (7.86 ± 1.10 vs. 7.93 ± 1.03 ms). Figure 4B summa-
rizes the effect of methAEA on GlyR-mediated mIPSCs in
the DDH. As in the SDH, methAEA significantly reduced
GlyR-mediated mIPSC frequency (0.37 ± 0.09 vs. 0.15 ±
0.03 Hz, n = 8) in DDH neurons. MethAEA, however, did
not affect mIPSC amplitude (62.4 ± 6.0 vs. 52.2 ± 6.8 pA),
rise time (0.63 ± 0.03 vs. 0.60 ± 0.09 ms), or decay time
constant (5.04 ± 0.68 vs. 5.02 ± 0.57 ms). In summary,
methAEA reduced mIPSC frequency but had no direct
effect on GlyRs located at synapses on either SDH or DDH
neurons.
Cannabinoid effects on GABAAR-mediated synaptic 
transmission
We next tested if methAEA had direct effects on GABAAR-
mediated mIPSCs in the SDH or DDH. Figure 5A summa-Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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GlyR-mediated synaptic transmission in the SDH and DDH Figure 2
GlyR-mediated synaptic transmission in the SDH and DDH. A representative traces showing continuous recordings of 
GlyR-mediated mIPSCs (holding potential - 70 mV) in the presence of TTX (1 μm), CNQX (10 μm), and bicuculline (10 μm) 
from an SDH (red traces) and a DDH neuron (blue traces). Note mIPSC frequency is considerably higher in DDH neurons. B 
individual mIPSCs from traces in A (aligned at rise onset) showing the amplitude variability in GlyR-mediated mIPSCs recorded 
in both the SDH (red traces) and DDH (blue traces). Inset shows averaged mIPSCs normalised to the same amplitude (same 
neurons in A). Note the slower decay time of GlyR-mediated mIPSCs in SDH neurons. C overlayed histograms comparing 
amplitude distributions of GlyR-mediated mIPSCs in SDH (red) and DDH (blue) neurons (n = 25 neurons for SDH and DDH). 
In the SDH distribution, only 10% of mIPSCs have amplitudes greater than 50 pA, whereas 35% of the mIPSCs in the DDH dis-
tribution are greater than 50 pA. Inset shows data presented as cumulative probability plots. D plots comparing group data for 
GlyR-mediated mIPSC decay time-constant and frequency in SDH and DDH neurons. GlyR-mediated mIPSC decay time-con-
stants were slower and mIPSC frequency was lower in SDH neurons.Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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rises the effect of methAEA on GABAAergic synaptic trans-
mission in SDH neurons. MethAEA produced a significant
reduction in mIPSC frequency (0.27 ± 0.05 vs. 0.18 ± 0.03
Hz, n = 6), without altering mIPSC amplitude (30.1 ± 1.7
vs. 28.1 ± 0.9 pA), or decay time constant (29.51 ± 7.39
vs. 37.52 ± 12.57 ms). The rise time of GABAAergic mIP-
SCs, however, was slowed by methAEA (1.89 ± 0.52 vs.
2.51 ± 0.69 ms). Figure 5B summarises the effect of meth-
AEA on GABAAR-mediated mIPSCs in DDH neurons. Bath
application of methAEA significantly reduced mIPSC fre-
quency (0.20 ± 0.04 vs. 0.05 ± 0.02 Hz, n = 7), but did not
affect mIPSC amplitude (19.6 ± 1.3 vs. 17.0 ± 1.1 pA), rise
time (1.58 ± 0.17 vs. 2.10 ± 0.51 ms), or decay time con-
stant (19.70 ± 3.52 vs. 23.10 ± 4.64 ms). These results sug-
gest the predominant effect of methAEA is to reduce
GABAAR-mediated mIPSC frequency, though the slowed
rise times suggest a postsynaptic effect of methAEA, possi-
bly involving a direct interaction on GABAARs.
Expression of glycine, GABAA, and CB1 receptor subunits in 
SDH and DDH
Because GlyR- and GABAAR-mediated mIPSC properties
differ markedly in SDH and DDH neurons, we next ana-
lysed subunit expression of both receptors in each region
using qPCR. Figure 6 summarises qPCR results for Gly-
and GABAAR subunits in the SDH and DDH. Data are pre-
sented as relative expression values. In the SDH (Figure
6A, left) Glyα1 is most highly expressed, followed by
Glyβ, Glyα3 and Glyα2, with negligible expression of
Glyα4. In the DDH (Figure 6A, right), Glyα1 is again the
most highly expressed subunit, followed by Glyβ. Glyα2,
Glyα3, and Glyα4 are expressed at much lower levels.
Comparison of each GlyR subunit in SDH versus DDH
showed Glyα1, Glyα2, Glyα4 and Glyβ were more highly
expressed in the DDH (Figure 6A). The results of GABAAR
subunit expression in the SDH (Figure 6B, left) showed no
significant differences in subunit expression. In the DDH
(Figure 6B, right), qPCR analysis also failed to resolve any
differences in GABAAR subunit expression. Comparison
of each GABAAR subunit in SDH versus DDH shows that
only expression levels of GABAα1 and GABAβ2 differed in
the two regions. Again higher expression levels were
detected in the DDH. Finally, comparison of CB1R relative
expression using qPCR in the SDH and DDH detected sig-
nificantly higher relative expression in the DDH (0.007 ±
0.001 vs. 0.025 ± 0.006, respectively).
Because both GlyR and GABAARs are heteropentamers at
native synapses we further analyzed all possible subunit
combinations for both receptor types in the SDH and
DDH. Comparisons for GlyR subunit combinations are
presented in Table 2. This analysis showed possible subu-
nit combinations are differentially weighted in the two
regions. For example, the Glyα1:GlyRα2 ratio is higher in
the SDH, whereas the Glyα1:GlyRα3 ratio is higher in the
DDH. This finding suggests an increased likelihood of
Glyα1:GlyRα2 combinations in the DDH and that
Glyα1:GlyRα3 combinations would be more prevalent in
the SDH. A similar analysis was conducted for GABAAR
subunits and none of the possible comparisons were sig-
nificantly different (data not shown).
Discussion
We found the properties of GlyR- and GABAA-mediated
mIPSCs to be clearly different in SDH and DDH, suggest-
ing the contribution of each receptor type to fast synaptic
inhibition differs between the two regions. An additional
aim of our experiments was to examine the action of an
endocannabinoid on the two ligand-gated ion channels
that are important for inhibitory signalling in the dorsal
horn of the spinal cord. Our experiments were driven by
three considerations: both Gly- and GABAARs have been
implicated in the onset and maintenance of various pain
states; the existence of a unique type of GlyR, containing
α3 subunits in the SDH of the mouse spinal cord; and
reports of a direct (allosteric) action of cannabinoids on
GlyRs in oocytes and dissociated neurons. We found no
evidence for a 'direct effect' of methAEA on GlyR function
in either the SDH or DDH. The rise time of GABAAR-medi-
ated mIPSCs, however, was slowed by methAEA in SDH
neurons, suggesting a direct effect on GABAAR-mediated
mIPSCs. Our real-time PCR data showed the balance of
Table 1: Properties of mIPSCs in mouse SDH and DDH neurons
mIPSC properties Channel properties
mIPSC
type
Region Amplitude
(pA)
Rise time
(ms)
Decay time
(ms)
Frequency
(Hz)
Chargeδ
(pA.ms)
n Conductance
(pS)
Open 
probability
(Po)
Channel
number
n
Glycine SDH 37.1 ± 3.9* 0.85 ± 0.07 8.5 ± 0.8* 0.15 ± 0.03* 364.5 ± 57.7 25 54.3 ± 1.6 .97 ± 0.01 10.3 ± 0.5* 8
DDH 64.7 ± 5.0 0.85 ± 0.04 5.5 ± 0.3 0.72 ± 0.13 456.6 ± 39.9 25 55.7 ± 1.8 99 ± 0.01 19.0 ± 5.3 11
GABAA SDH 25.6 ± 2.4 1.97 ± 0.18* 23.0 ± 3.2* 0.21 ± 0.08 717.3 ± 75.5* 14 22.7 ± 1.7 0.76 ± 0.04* 18.5 ± 1.6* 8
DDH 25.3 ± 2.0 1.49 ± 0.10 18.9 ± 1.6 0.18 ± 0.04 486.3 ± 52.4 18 22.4 ± 2.0 0.94 ± 0.02 12.9 ± 1.0 11
* indicates significant differences for SDH and DDH values
δ mIPSC charge calculated in Axograph using averages for peak amplitude, rise- and decay timesMolecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
Page 8 of 16
(page number not for citation purposes)
GABAAR-mediated synaptic transmission in the SDH and DDH Figure 3
GABAAR-mediated synaptic transmission in the SDH and DDH. A representative traces showing continuous record-
ings of GABAAR-mediated mIPSCs (holding potential - 70 mV) in the presence of TTX (1 μm), CNQX (10 μm), and strychnine 
(1 μm) from an SDH (red traces) and a DDH neuron (blue traces). Note similar mIPSC frequency in the neurons from the two 
regions. B individual mIPSCs from traces in A (aligned at rise onset) showing amplitude variability of GABAAR-mediated mIP-
SCs in both SDH (red traces) and DDH (blue traces). Inset shows averaged mIPSCs normalised to the same amplitude (same 
neurons as in A). Note the slower decay time of GABAAR-mediated mIPSCs in SDH neurons. C overlayed group data histo-
grams comparing amplitude distributions for GABAAergic mIPSCs in SDH (red) and DDH (blue) neurons (n = 14 and 18 for 
SDH and DDH, respectively). The overlap of the two distributions indicates that GABAAR-mediated mIPSC amplitudes are 
similar in SDH and DDH neurons. Inset shows data presented as cumulative distribution plots. D plots comparing group data 
for GABAAR-mediated mIPSC decay time-constant and frequency in SDH and DDH neurons. GABAAR-mediated mIPSC decay 
time-constants were significantly slower in SDH neurons, however, mIPSC frequency was similar in both regions.Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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Gly- and GABAAR subunit expression differed somewhat
in SDH and DDH. For GlyRs, the α1 and β subunits dom-
inate in both SDH and DDH, expression of the α2 GlyR
subunit was higher in DDH, whereas α3 subunits where
expressed equally in both regions. For GABAARs, α1 and
β2 subunit expression was higher in the DDH. In contrast
to previous reports, using immunohistochemistry, we
found CB1 receptor expression to be higher in the DDH.
Contributions of glycine- and GABAARs in dorsal horn 
function
To our knowledge this study is the first comparison of
Gly- and GABAAR properties in superficial and deep lam-
inae of the mouse spinal cord dorsal horn. Previously, we
have used parasagittal slices (vs. transverse in this study)
to compare Gly- and GABAAR-mediated mIPSCs in super-
ficial laminae (I-II) of wildtype C57/Bl6 mice and the
Effect of methanandamide on GlyR-mediated synaptic transmission in SDH and DDH neurons Figure 4
Effect of methanandamide on GlyR-mediated synaptic transmission in SDH and DDH neurons. A plot showing 
GlyR-mediated mIPSC frequency (holding potential - 70 mV) in an SDH neuron during bath application of methAEA (5 μm, 
upper bar). mIPSC frequency declines in the presence of methAEA. Middle traces are averaged mIPSCs (n = 15) under control 
conditions, and after 10 minutes in methAEA. Black bars above x-axis indicate when averaged mIPSCs were obtained. Plot on 
right presents group data summarising proportional changes in GlyR-mediated mIPSC properties in methAEA. mIPSC fre-
quency was reduced in methAEA. mIPSC peak amplitude, rise time, and decay time-constant were unaltered. B Effect of meth-
AEA on GlyR-mediated mIPSCs in DDH neurons (data presented in same format as A). methAEA also reduced GlyR-mediated 
mIPSC frequency in DDH neurons without altering mIPSC peak amplitude, rise time, or decay time-constant. Note, each data 
point in left panels in A and B represent averaged instantaneous mIPSC frequency, binned in 15 s intervals.Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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GlyR mutants spastic and oscillator [39]. As in the present
study, a greater proportion of SDH neurons received
GABAAR- versus GlyR-mediated inhibition. GABAAR - and
GlyR-mediated mIPSC amplitude was also similar to that
observed in wildtype mice in our previous work. In paras-
agittal slices, however, mIPSC frequency was higher and
decay time constants were slower for both Gly- and
GABAARs. The higher mIPSC frequency is probably due to
the rostro-caudal orientation of the dendritic trees of SDH
neurons [45] as their parasagittal orientation would result
in retention of more synapses in a slice. It is unclear, how-
ever, why decay time constants are slower in parasagittal
slices.
Our data show that the contribution of GlyRs to fast
inhibitory synaptic transmission is greater in the DDH
Effect of methanandamide on GABAAR-mediated synaptic transmission in SDH and DDH neurons Figure 5
Effect of methanandamide on GABAAR-mediated synaptic transmission in SDH and DDH neurons. A Plot 
showing GABAAR-mediated mIPSC frequency (holding potential - 70 mV) in an SDH neuron during bath application of meth-
AEA (5 μm, upper bar). mIPSC frequency declines significantly in the presence of methAEA. Middle traces are averaged mIPSCs 
(n = 15) in control conditions and after 10 minutes in methAEA. Black bars above x-axis indicate when averaged mIPSCs were 
obtained. Plot on right summarizes proportional changes to GABAAR-mediated mIPSC properties in methAEA. mIPSC fre-
quency is reduced and rise time is slowed, however, mIPSC peak amplitude and decay time constant are not altered. B Effect 
of methAEA on GABAAR-mediated mIPSCs in DDH neurons (presented in same format as A). methAEA significantly reduced 
GABAAR-mediated mIPSC frequency, however, mIPSC peak amplitude, rise time, and decay time-constant were not altered in 
DDH neurons. Each data point on left panels in A and B represent averaged instantaneous mIPSC frequency, binned in 15 s 
intervals.Molecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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Gly- and GABAA-subunit expression in the SDH and DDH Figure 6
Gly- and GABAA-subunit expression in the SDH and DDH. A plots summarising qPCR analysis for GlyR subunits. Bars 
represent relative expression of GlyR subunits in the SDH and DDH. The α1 and β subunits were the most highly expressed in 
both SDH and DDH, whereas expression of the α4 subunit was negligible. The α2 and α3 subunits were expressed at lower 
levels in both regions. Overall, α1, β, and α2-4 subunits were expressed at significantly different levels in both regions. Note, 
scale on the y-axis has been broken and expanded to facilitate comparison of subunits showing lower expression levels. B plots 
summarising qPCR analysis for GABAAR subunits. Bars represent relative expression of GABAAR subunits in the SDH and 
DDH. Overall, GABAAR subunit expression was more variable than that observed for GlyR subunits. No significant differences 
in expression levels were identified, however, the expression profile for each subunit was similar in both SDH and DDH (ie, 
higher expression of α2, α3, β3, and γ2).
Table 2: Glycine receptor subunit expression ratio's in SDH and DDH
Glyα1G l y α2G l y α3G l y α4G l y β
SDH DDH SDH DDH SDH DDH SDH DDH SDH DDH
Glyα1 0.04 ± 0.00 0.08 ± 0.01 0.06 ± 
0.02*
0.02 ± 
0.00*
0.00 ± 0.00 0.00 ± 0.00 0.39 ± 0.10 0.51 ± 0.04
Glyα2 29.1 ± 2.8 * 12.6 ± 1.1 * 1.8 ± 0.8 * 0.20 ± 0.01 
*
0.12 ± 0.00 
*
0.05 ± 0.00 
*
12.5 ± 0.4 * 7.6 ± 1.3 *
Glyα3 21.2 ± 4.2 * 63.2 ± 6.9 * 0.78 ± 0.18 
*
5.0 ± 0.2 * 0.11 ± 0.0 * 0.23 ± 0.01 
*
18.7 ± 6.6 33.5 ± 2.8
Glyα4 252.6 ± 
20.8
269.8 ± 
22.0
8.7 ± 0.3 * 21.4 ± 0.3 * 9.1 ± 0.3 * 4.3 ± 0.3 * 166.2 ± 
53.9
467.3 ± 3.3
Glyβ 3.7 ± 1.6 1.5 ± 0.2 0.08 ± 0.00 
*
0.11 ± 0.01 
*
0.07 ± 0.1 0.03 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
* indicates significant difference in subunit ratios between SDH and DDHMolecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
Page 12 of 16
(page number not for citation purposes)
versus SDH, whereas GABAAR-mediated inhibition
appears to be equally important in both regions. In rat,
Cronin et al. (2004) used c-Fos expression to functionally
assess tonic inhibitory drive mediated by GlyRs and
GABAARs in dorsal horn and suggested GlyR-mediated
mechanisms are more important for setting inhibitory
tone in DDH. Our data are consistent with this finding
and other data for rats. For example glycine-containing
neurons [46,47] and glycine terminals are more concen-
trated in deeper dorsal horn laminae [48]. In contrast,
GABA containing neurons and terminals populate the
entire dorsal horn [46,49]. Thus, our mouse data are con-
sistent with a clear regional variation of glycinergic and
GABAAergic inhibition in the rodent dorsal horn.
In mouse, Gly- and GABAARs with differing physiological
properties contribute to fast synaptic inhibition in the
SDH and DDH. Our data can be compared to a recent
study in rat [50], even though the definition of "deep"
dorsal horn varied from ours (laminae III-IV vs. laminae
IV-VI). In the rat study, a greater proportion of neurons in
the DDH received GlyR-mediated mIPSCs and receptor
properties were similar in each region. We also found
almost all neurons received GlyR-mediated mIPSCs in the
mouse DDH, however, the properties of GlyRs differed
markedly in SDH versus DDH. Specifically, mIPSC fre-
quency and amplitudes were higher, and mIPSC decay
times were faster in the DDH. Developmental processes
may explain these differences as the rat study used
younger animals (P10-15 rats vs. P17-37 mice). The
importance of GABAAR- and GlyR- mediated inhibitory
processing mechanisms changes in SDH neurons during
postnatal development (at least from P0-14), with glycin-
ergic transmission maturing later [51]. Exactly when
inhibitory mechanisms are functionally mature in rat is
not known. In mice, however, we have shown that GlyR
properties do not change in SDH neurons after P17 [39].
Moreover, SDH neurons are certainly electrically mature
in the P17-37 mice used in this study [33]. It is unknown
whether DDH neurons are mature by P17. Together, this
work suggests significantly more GlyRs, with faster kinet-
ics, contribute to GlyR-mediated inhibition in mouse
DDH.
GlyRs in mouse SDH and DDH differ in their decay times
(8-10 ms vs. 4-5 ms, respectively). The fast decay times of
GlyR-mediated mIPSCs in DDH neurons (4-5 ms) match
previous reports for both mice [52] and rats [53,54] for
GlyRs that contain α1 and β subunits. One potential
explanation for the slower kinetics of SDH versus DDH
GlyRs in mouse is the existence of a distinctly expressed
type of GlyR, containing α3 subunits, in lamina II of the
mouse SDH [22]. As for other GlyRs, subunit composition
(ie, Glyα1 vs. Glyα2) can shape channel kinetics [53,55].
This, however, does not appear to be the case for α3 con-
taining GlyRs in the mouse SDH as decay times, at least
for evoked GlyR-mediated currents, are identical in
wildtype and α3 knockout mice [22]. One explanation is
that the somato-dendritic distribution of inhibitory syn-
apses may differ for SDH versus DDH neurons. For exam-
ple, preferential localization of GlyRs on dendrites would
decrease the amplitude and slow the decay time of GlyR-
mediated mIPSCs [56]. Such dendritic filtering effects
would, however, also slow rise times of GlyR-mediated
mIPSCs and this was not the case (Table 1). Thus, future
experiments are needed to determine why the kinetics of
GlyR channels in the SDH and DDH differ.
In contrast to the marked difference in the contribution of
GlyRs to inhibition in the SDH and DDH, GABAAR-medi-
ated inhibition appears equally important in both spinal
cord regions. These observations are consistent with
immunohistochemical data in rat showing that GABA-
containing neurons, GABA positive terminals and
GABAARs are equally distributed across the dorsal horn.
The only major difference we observed in mouse dorsal
horn was a slower decay time constant (23 vs. 18 ms) in
SDH versus DDH neurons. The faster kinetics of mIPSCs
in DDH neurons, are consistent with higher expression of
the α1 GABAAR subunit in deeper lamina [57] as incorpo-
ration of the α1 subunit decreases channel open time and
mIPSC decay time [58,59]. Thus, in mice, GABAAR-medi-
ated inhibitory transmission appears equally important
across the entire dorsal horn, however, GABAARs in the
DDH have faster kinetics.
The different decay times we report for both GlyR- and
GABAAR-mediated mIPSCs in mouse SDH versus DDH
point to varying subunit composition. Our qPCR data for
GlyR subunits show that the balance of GlyR-subunit
expression differs in SDH and DDH. Not surprisingly, the
α1 and β subunits of the GlyR, the ubiquitous adult form
of the receptor [60,61], dominate in both regions. The α2
subunit, however, is expressed at higher levels in the
DDH. This can not explain the slower kinetics of SDH
mIPSCs, as developmental studies in spinal cord [55] and
brainstem neurons [39,53] show GlyRs containing α2
subunits have slower kinetics. Interestingly, our qPCR
data did not show higher α3 expression in the SDH as
reported by Harvey et al., (2004) using immunohisto-
chemistry. A scenario where α3 subunit is preferentially
directed to synaptic locations in SDH, whereas in DDH
the protein remains at extrasynaptic locations would
explain these differences. This needs to considered when
comparing electrophysiological data, which only assesses
synaptic receptors versus qPCR data which assesses subu-
nit expression without considering location. Our qPCR
data for GABAAR subunits showed there was significantlyMolecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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greater expression of GABAAR α1 and β2 subunits in the
DDH versus the SDH. These data are consistent with
reports showing GABAARs containing α1 subunits have
faster kinetics [58,59].
Endocannabinoid actions on fast inhibitory receptors in 
SDH and DDH
Our data show clearly that the endocannabinoid ana-
logue, methAEA (5 μM), reduces GlyR- and GABAAR-
mediated mIPSC frequency in both SDH and DDH neu-
rons. These findings are consistent with the "in vivo" view
of endcannabinoid action, whereby they are released
postsynaptically and act retrogradely at presynaptic termi-
nals to reduce neurotransmitter release [62-66]. The
reduced mIPSC frequency we measured in the presence of
methAEA is also consistent with immunohistochemical
investigations showing that the CB1R is expressed on the
presynaptic terminals of local circuit neurons, descending
inputs, as well as peripheral sensory afferents in the spinal
cord [25,62,67]
The negative action of methAEA on both GlyR- and
GABAAR- mediated inhibition appears to be at odds with
the well-documented antinociceptive effects of cannabi-
noids. In vivo administration of GlyR and GABAAR antag-
onists produces hyperalgesia and tactile allodynia rather
than analgesia [68,69]. These apparently conflicting
observations made using in vitro and in vivo preparations
emphasise that the net effect of cannabinoids on spinal
circuits determines dorsal horn output. It is well known
that cannabinoids also decrease excitatory drive in the
dorsal horn, based on reduction of glutamate-mediated
mEPSCs [62,70]. New information using paired recording
techniques in the SDH indicates that most (~70%) of the
connections within lamina II are excitatory [71]. These
new data fit with the "net effect" hypothesis. Perhaps
these comparisons emphasize the lack of information on
specific circuits in spinal cord pain pathway and the roles
of various interneuronal populations in dorsal horn func-
tion)[72].
Because two recent reports suggest cannabinoids can
directly modulate GlyRs in isolated neurons or oocytes
[31,32], we tested the effects of methAEA on GlyR-medi-
ated mIPSCs in both SDH and DDH neurons. We found
no evidence for a 'direct effect' of methAEA on GlyR func-
tion in either SDH or DDH. There are several explanations
for why we did not observe a direct effect of methAEA on
GlyRs. First, our study employed a more 'physiologically
intact' preparation where factors such as receptor cluster-
ing, local glycine concentration and subunit composition
would differ markedly. Second, recent reports suggest the
direct effects of cannabinoids on recombinant GlyRs is
subunit-specific, and glycine-concentration dependent
[73].
We also tested for direct effects of cannabinoids on
GABAAergic mIPSCs. In both SDH and DDH neurons
methAEA reduced mIPSC frequency and did not alter
mIPSC amplitude. Similar responses have been reported
in the cerebellum [74]. In addition, we observed a signifi-
cant effect of methAEA on GABAAR-mediated mIPSC rise
time, however, this was confined to SDH neurons. This is
perhaps not surprising, as GABAARs are modulated by a
multitude of exogenous and endogenous substances. For
example, the benzodiazepines [75], gaseous and intrave-
nous anaesthetics [76], alcohols [77], neurosteroids [78]
and zinc [79] can all positively modulate the GABAAR
responses to GABA via allosteric actions on the receptor
complex. Thus, cannabinoids may prove to be yet another
modulatory agent of GABAAR-mediated signaling.
Implications for spinal cord processing of sensory 
information
Previous work has shown that the SDH and DDH receive
different types of peripheral input, project to different
supraspinal targets and exhibit considerable variation in
their intrinsic connectivity [18,19,71]. We propose that
clear differences also exist in inhibitory control mecha-
nisms within each region. Glycinergic signalling domi-
nates in the DDH, whereas GABAA signalling is equally
important in both regions. Finally, there appears to be
need for an inhibitory system with fast and slow kinetics
within both superficial and deep regions of the mouse spi-
nal cord. GlyR-mediated inhibition is more important in
deep regions of the dorsal horn, which preferentially
receive peripheral inputs from axons with high conduc-
tion velocities [3,12]. The existence of large and fast inhib-
itory inputs in the DDH would be well suited to modulate
the effects of such inputs. In contrast, smaller and slower
GABAAR-mediated inhibition appears to be equally
important in both superficial and deep regions of the spi-
nal cord dorsal horn. These features suggest GABAAR-
mediated inhibition is more important for fine-tuning the
effects of a functionally wider range of peripheral inputs.
Suppression of inhibitory signalling in the dorsal horn,
which occurs in certain chronic pain states, can lead to
hypersensitivity and tactile allodynia [68,80-82]. Both
SDH and DDH neurons have been implicated in this form
of plasticity, reinforcing the notion that both regions of
the dorsal horn play key roles in nociception even though
the SDH preferentially receives nociceptive input. The seg-
regation of excitation and information processing in the
two regions is hypothesised to play a key role in the segre-
gation of noxious and innocuous sensory experience. The
importance of both glycinergic and GABAAergic inhibi-
tion in this segregation was clearly illustrated in recent cal-
cium imaging experiments in spinal cord slices [83]. In
the control condition, dorsal root stimulation resulted in
discrete and localized excitation that was restricted to theMolecular Pain 2009, 5:65 http://www.molecularpain.com/content/5/1/65
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SDH. When the same preparation was stimulated under
conditions where inhibition was blocked, excitation
spread from the SDH to DDH and even contralaterally.
These findings highlight the importance of inhibitory
control of cross talk between the SDH and DDH. Conse-
quently, a greater understanding of the properties of
inhibitory mechanisms in the two regions will help iden-
tify new strategies for treating nociceptive dysfunction in
the spinal cord dorsal horn.
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